PLC expands Heart Laser Transmyocardial Revascularization (TMR) trials
This article was originally published in Clinica
Executive Summary
PLC Systems has FDA approval to expand its trials of Transmyocardial Revascularization (TMR) using the company's Heart Laser as sole therapy for end-stage coronary artery disease.